SCHEMBL4332713

SCHEMBL4332713

O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CC1CCOC1

nearest known ligand 0.83

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.83
SCN5A Q14524 15/20 0.83
KCNH2 Q12809 14/20 0.83
KCNQ2 O43526 1/20 0.62
KCNA5 P22460 1/20 0.62
SCN2A Q99250 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328335 0.91 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4325751 0.85 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4465347 0.85 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4459445 0.85 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4323874 0.84 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL3889439 0.84 SCN9A (0.82) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4463844 0.82 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4321010 0.80 SCN9A (1.00) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL4339063 0.79 SCN9A (0.83) SCN9ASCN5AKCNH2KCNQ2KCNA5
SCHEMBL13579090 0.79 SCN9A (0.77) SCN9ASCN5AKCNH2KCNQ2KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145721-A1 ISOINDOLINE DERIVATIVES COMPRISING PHENYL GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO claimed
WO-2009145721-A1 ISOINDOLINE DERIVATIVES COMPRISING PHENYL GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed
WO-2009145721-A1 ISOINDOLINE DERIVATIVES COMPRISING PHENYL GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed